BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 21725645)

  • 1. Oligodendroglial ganglioglioma.
    Yamashita S; Yokogami K; Niibo T; Takeishi G; Ikeda T; Miyata S; Uehara H; Fukushima T; Nakazato Y; Takeshima H
    Brain Tumor Pathol; 2011 Oct; 28(4):311-6. PubMed ID: 21725645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
    Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
    Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glioneuronal tumor with neuropil-like islands (GTNI): a report of 8 cases with chromosome 1p/19q deletion analysis.
    Barbashina V; Salazar P; Ladanyi M; Rosenblum MK; Edgar MA
    Am J Surg Pathol; 2007 Aug; 31(8):1196-202. PubMed ID: 17667543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular analysis of chromosome 1, 10 and 19 abnormalities in human oligodendroglial tumors: relationship between frequency of LOH grade, age and gender.
    Gresner SM; Rieske P; Wozniak K; Piaskowski S; Jaskolski DJ; Skowronski W; Golanska E; Sikorska B; Liberski PP
    Clin Neuropathol; 2006; 25(1):18-24. PubMed ID: 16465770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pleomorphic xanthoastrocytoma and oligodendroglioma: collision of 2 morphologically and genetically distinct anaplastic components.
    Hattab EM; Martin SE; Shapiro SA; Cheng L
    J Neurosurg; 2011 Jun; 114(6):1648-53. PubMed ID: 21214337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetically distinct astrocytic and oligodendroglial components in oligoastrocytomas.
    Qu M; Olofsson T; Sigurdardottir S; You C; Kalimo H; Nistér M; Smits A; Ren ZP
    Acta Neuropathol; 2007 Feb; 113(2):129-36. PubMed ID: 17031656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlations between molecular profile and tumor location in Chinese patients with oligodendroglial tumors.
    Huang L; Jiang T; Yuan F; Li GL; Liu EZ; Wang ZC
    Clin Neurol Neurosurg; 2008 Dec; 110(10):1020-4. PubMed ID: 18845382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gliosarcoma arising in oligodendroglial tumors ("oligosarcoma"): a clinicopathologic study.
    Rodriguez FJ; Scheithauer BW; Jenkins R; Burger PC; Rudzinskiy P; Vlodavsky E; Schooley A; Landolfi J
    Am J Surg Pathol; 2007 Mar; 31(3):351-62. PubMed ID: 17325476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oligodendroglial tumors with marked desmoplasia: clinicopathologic and molecular features of 7 cases.
    Jentoft M; Giannini C; Rossi S; Mota R; Jenkins RB; Rodriguez FJ
    Am J Surg Pathol; 2011 Jun; 35(6):845-52. PubMed ID: 21552114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Grade II oligodendroglioma localized to the corpus callosum.
    Monaco EA; Armah HB; Nikiforova MN; Hamilton RL; Engh JA
    Brain Tumor Pathol; 2011 Oct; 28(4):305-9. PubMed ID: 21833577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluorescence in situ hybridization (FISH) on touch preparations: a reliable method for detecting loss of heterozygosity at 1p and 19q in oligodendroglial tumors.
    Scheie D; Andresen PA; Cvancarova M; Bø AS; Helseth E; Skullerud K; Beiske K
    Am J Surg Pathol; 2006 Jul; 30(7):828-37. PubMed ID: 16819324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined 1p/19q loss in oligodendroglial tumors: predictive or prognostic biomarker?
    Weller M; Berger H; Hartmann C; Schramm J; Westphal M; Simon M; Goldbrunner R; Krex D; Steinbach JP; Ostertag CB; Loeffler M; Pietsch T; von Deimling A;
    Clin Cancer Res; 2007 Dec; 13(23):6933-7. PubMed ID: 18056167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histological growth patterns and genotype in oligodendroglial tumours: correlation with MRI features.
    Jenkinson MD; du Plessis DG; Smith TS; Joyce KA; Warnke PC; Walker C
    Brain; 2006 Jul; 129(Pt 7):1884-91. PubMed ID: 16670176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prognostic impact of histology and 1p/19q status in anaplastic oligodendroglial tumors.
    McDonald JM; See SJ; Tremont IW; Colman H; Gilbert MR; Groves M; Burger PC; Louis DN; Giannini C; Fuller G; Passe S; Blair H; Jenkins RB; Yang H; Ledoux A; Aaron J; Tipnis U; Zhang W; Hess K; Aldape K
    Cancer; 2005 Oct; 104(7):1468-77. PubMed ID: 16088966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Challenging diagnosis: oligodendroglioma versus extraventricular neurocytoma.
    Mut M; Güler-Tezel G; Lopes MB; Bilginer B; Ziyal I; Ozcan OE
    Clin Neuropathol; 2005; 24(5):225-9. PubMed ID: 16167546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of molecular and clinical factors on patient outcome in oligodendroglioma from 20 years' experience at a single centre.
    Parkinson JF; Afaghi V; Payne CA; Buckland ME; Brewer JM; Biggs MT; Little NS; Wheeler HR; Cook RJ; McDonald KL
    J Clin Neurosci; 2011 Mar; 18(3):329-33. PubMed ID: 21247767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allelic status of 1p and 19q in oligodendrogliomas and glioblastomas: multiplex ligation-dependent probe amplification versus loss of heterozygosity.
    Franco-Hernández C; Martínez-Glez V; de Campos JM; Isla A; Vaquero J; Gutiérrez M; Casartelli C; Rey JA
    Cancer Genet Cytogenet; 2009 Apr; 190(2):93-6. PubMed ID: 19380026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pleomorphic xanthoastrocytoma as a component of a temporal lobe cystic ganglioglioma: a case report.
    Sugita Y; Irie K; Ohshima K; Hitotsumatsu T; Sato O; Arimura K
    Brain Tumor Pathol; 2009; 26(1):31-6. PubMed ID: 19408095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor location and growth pattern correlate with genetic signature in oligodendroglial neoplasms.
    Zlatescu MC; TehraniYazdi A; Sasaki H; Megyesi JF; Betensky RA; Louis DN; Cairncross JG
    Cancer Res; 2001 Sep; 61(18):6713-5. PubMed ID: 11559541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluorescent in situ hybridization on isolated tumor cell nuclei: a sensitive method for 1p and 19q deletion analysis in paraffin-embedded oligodendroglial tumor specimens.
    Gelpi E; Ambros IM; Birner P; Luegmayr A; Drlicek M; Fischer I; Kleinert R; Maier H; Huemer M; Gatterbauer B; Anton J; Rössler K; Budka H; Ambros PF; Hainfellner JA
    Mod Pathol; 2003 Jul; 16(7):708-15. PubMed ID: 12861068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.